Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
In This Section
More Information
Health in the Landscape of Life
Enabling the healthscape, the ecosystem outside the clinic, requires improving the system to pay for health drivers.
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Give Faculty Students Alumni Directory

Psychiatry & Behavioral Sciences Grand Rounds: Transcranial Magnetic Stimulation for Psychiatric Disorders

Location: In-Person: Health Learning Building (HLB) Auditorium, 1.111

Address: 1501 Red River St, Austin, Texas | View Map »

Date: Tuesday, June 6, 2023

Time: 12–1:30 p.m.

Contact: Barbara Springer

About the Event

In this installment of Psychiatry and Behavioral Grand Rounds, Paul E. Holtzheimer, M.D., presents “Transcranial Magnetic Stimulation for Psychiatric Disorders.” Holtzheimer is a professor of psychiatry and surgery and the Geisel School of Medicine at Dartmouth.

For more information about the event, email Barbara Springer.

Learning Objectives

By the end of this presentation, the audience participant should be able to:

  • Describe what transcranial magnetic stimulation (TMS) is and how it may potentially work.
  • Recognize the data supporting TMS as a treatment for depression.
  • Assess the potential for TMS as a treatment for other psychiatric conditions, such as posttraumatic stress disorder, obsessive-compulsive disorder and addiction.

Target Audience

  • Primary: Psychiatrists, social workers, psychologists, nurses and other mental health professionals
  • Secondary: Other health care professionals


This activity has been designed to promote some of the following desired physician attributes and competencies:

  • ACGME: Patient Care; Medical Knowledge; Practice-Based Learning and Improvement; Interpersonal and Communication Skills; Professionalism; Systems-Based Practice
  • IOM: Provide patient-centered care; Work in interdisciplinary teams; Employ evidence-based practice; Apply quality improvement; Utilize informatics
  • IECC: Interprofessional Teamwork & Team-based Practice; Interprofessional Communication; Values & Ethics for Interprofessional Practice

Speaker Disclosure

Paul E Holtzheimer, MD, speaker for this educational activity, has received royalties from UpToDate and Oxford University Press.

Planner Disclosure

Mark Townsend, M.D.; R. Lowell McRoberts, M.D.; Jorge Almeida, M.D., Ph.D.; Carol Alter, M.D.; Lloyd S. Berg, Ph.D.; and Barbara Springer, planners for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Jeffrey Newport, M.D., M.S., MDiv, planner for this educational activity, received grants/research funds from Navitor Pharmaceuticals and Sage Therapeutics. He is a consultant for Sage Therapeutics.

Charles B. Nemeroff, M.D., Ph.D., planner for this educational activity, is a consultant for ANeuroTech (division of Anima BV), Taisho Pharmaceutical, Inc.,Takeda, Signant Health, Sunovion Pharmaceuticals, Inc., Janssen Research & Development LLC, Magstim, Inc., Navitor Pharmaceuticals, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Acadia Pharmaceuticals, Axsome, Sage Therapeutics, BioXcel Therapeutics, Silo Pharma, XW Pharma, Neuritek, Engrail Therapeutics, and Corcept Therapeutics Pharmaceuticals Company.

He is a stock shareholder (directly purchased) of Xhale, Seattle Genetics, Antares, BI Gen Holdings, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness.

Nemeroff is on the Scientific Advisory Boards for ANeuroTech (division of Anima BV), Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Magnolia CNS, and on the Board of Directors of Xhale Smart, Inc.

He holds patents for the following: Method and devices for transdermal delivery of lithium (US 6,375,990B1), Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)

The CME Advisory Committee, reviewers of this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement

The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas at Austin Dell Medical School designates this internet live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.